Read More Details
Finally We wish PressBee provided you with enough information of ( Laekna Therapeutics Receives IND Approvals in China and US for Phase Ib/III Global Multi-center Clinical Study of Afuresertib in combination with fulvestrant for patients with HR+/HER2- breast cancer )
Also on site :
- 4 semis catch fire, causing explosions at Weld County truck stop
- Sanctions link: France demands release of nationals from Iran
- Supreme Court clears way for deportation to South Sudan of several immigrants with no ties there